Available data in Caucasians suggest that lean NAFLD patients are characterised by impaired glucose metabolism, evidence of dysfunctional adipose tissue and a higher rate of carriage of the PNPLA3 minor allele [2]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.